Various studies have tied the effectiveness of daruhaldi with obesity work by Kim et al. [42] shows that berberine treatment enhances AMPK activity in adipocytes, resulting in elevated GLUT1 expression and improved glucose uptake. This evidence concerns the gene SLC2A1 and obesity due to melanocortin 4 receptor deficiency.